B1962
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for B1962, covering 2024-12-09 to 2024-12-09. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors [Phase 2]